Diabetes Mellitus Clinical Trials in Singapore

8 recruitingSingapore, Singapore

Showing 18 of 8 trials

Recruiting
Phase 3

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Cardiovascular DiseasesHypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim11,800 enrolled1153 locationsNCT07064473
Recruiting
Phase 1

A Study to Evaluate the Effect of Fasting Duration and Tirzepatide Withholding on the Amount of Food and Fluid in the Stomach in Participants With Type 2 Diabetes Mellitus and Participants With Overweight or Obesity Without Type 2 Diabetes Mellitus

ObesityDiabetes Mellitus, Type 2Overweight
Eli Lilly and Company40 enrolled1 locationNCT07299084
Recruiting
Phase 1

A Study to Evaluate the Effect of Fasting Duration and Dulaglutide (LY2189265) Withholding on Gastric Retention in Participants With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus (T2DM)
Eli Lilly and Company20 enrolled1 locationNCT07313813
Recruiting
Not Applicable

WeArable teChnology daTa driVen digitAl healTh cOachINg (ACTIVATION)- A Mixed-methods Study

HypertensionType 2 Diabetes Mellitus (T2DM)Prediabetes+3 more
Alexandra Hospital1,700 enrolled1 locationNCT06752772
Recruiting
Not Applicable

App-based Diabetes Management and Community-based Interventions

Diabetes Mellitus, Type 2
Singapore General Hospital150 enrolled2 locationsNCT06688903
Recruiting
Not Applicable

App-based Motivational Interviewing and Artificial Intelligence in Diabetes Management

Diabetes Mellitus, Type 2
Singapore General Hospital525 enrolled3 locationsNCT06214520
Recruiting
Not Applicable

The PACT (Patient Activation Through Conversations) Study

Diabetes MellitusDiabetes Mellitus, Type 2
National Healthcare Group Polyclinics432 enrolled3 locationsNCT06444074
Recruiting
Not Applicable

Health Coaching, Continuous Glucose Monitoring and AI Mobile App in Diabetes

Diabetes Mellitus, Type 2
Singapore General Hospital400 enrolled3 locationsNCT06028139